Compare Stocks: IMDX vs. BNR vs. ISPC vs. BDSX
Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
IMDXBNRISPCBDSX
Market Snapshot
Current market context for the selected companies.
IMDX
$4.32
Market Cap
$145.30M
Sector
Healthcare
Industry
Diagnostics & Research
Data through
2026-08-26
BNR
$9.93
Market Cap
103.35M
Sector
Healthcare
Industry
Diagnostics & Research
Data through
2026-08-26
ISPC
$1.63
Market Cap
$4.03M
Sector
Healthcare
Industry
Diagnostics & Research
Data through
2026-08-26
BDSX
$30.63
Market Cap
$296.22M
Sector
Healthcare
Industry
Diagnostics & Research
Data through
2026-08-26
Performance
Absolute returns and relative performance versus SPY.
| Metric | IMDX | BNR | ISPC | BDSX |
|---|---|---|---|---|
| 1 Month | -6.3% | +8.0% | -13.8% | +45.6% |
| 1 Month vs SPY | -9.6% | +4.7% | -17.1% | +42.3% |
| 3 Months | -32.6% | -18.4% | -51.3% | +106.8% |
| 3 Months vs SPY | -34.6% | -20.5% | -53.3% | +104.8% |
| 6 Months | -24.9% | -58.8% | -85.3% | +136.9% |
| 6 Months vs SPY | -35.3% | -69.2% | -95.8% | +126.5% |
| 1 Year | +73.5% | +15.4% | -95.0% | +212.6% |
| 1 Year vs SPY | +54.3% | -3.7% | -114.2% | +193.4% |
| 2 Years | +43.0% | +59.0% | -99.4% | -14.0% |
| 2 Years vs SPY | +6.5% | +22.5% | -136.0% | -50.5% |
Growth & Profitability
Operating growth, margins and capital efficiency.
Valuation
Common valuation multiples shown side by side.
Cash Flow & Balance Sheet
Cash generation and leverage context.
Earnings Outlook
Upcoming earnings expectations when available.